Literature DB >> 28870269

Failure to Communicate: Transmission of Extensively Drug-Resistant bla OXA-237-Containing Acinetobacter baumannii-Multiple Facilities in Oregon, 2012-2014.

Genevieve L Buser1, P Maureen Cassidy1, Margaret C Cunningham1, Susan Rudin2, Andrea M Hujer2, Robert Vega1, Jon P Furuno3, Steven H Marshall2, Paul G Higgins4, Michael R Jacobs5, Meredith S Wright6, Mark D Adams6, Robert A Bonomo2, Christopher D Pfeiffer7, Zintars G Beldavs1.   

Abstract

OBJECTIVE To determine the scope, source, and mode of transmission of a multifacility outbreak of extensively drug-resistant (XDR) Acinetobacter baumannii. DESIGN Outbreak investigation. SETTING AND PARTICIPANTS Residents and patients in skilled nursing facilities, long-term acute-care hospital, and acute-care hospitals. METHODS A case was defined as the incident isolate from clinical or surveillance cultures of XDR Acinetobacter baumannii resistant to imipenem or meropenem and nonsusceptible to all but 1 or 2 antibiotic classes in a patient in an Oregon healthcare facility during January 2012-December 2014. We queried clinical laboratories, reviewed medical records, oversaw patient and environmental surveillance surveys at 2 facilities, and recommended interventions. Pulsed-field gel electrophoresis (PFGE) and molecular analysis were performed. RESULTS We identified 21 cases, highly related by PFGE or healthcare facility exposure. Overall, 17 patients (81%) were admitted to either long-term acute-care hospital A (n=8), or skilled nursing facility A (n=8), or both (n=1) prior to XDR A. baumannii isolation. Interfacility communication of patient or resident XDR status was not performed during transfer between facilities. The rare plasmid-encoded carbapenemase gene bla OXA-237 was present in 16 outbreak isolates. Contact precautions, chlorhexidine baths, enhanced environmental cleaning, and interfacility communication were implemented for cases to halt transmission. CONCLUSIONS Interfacility transmission of XDR A. baumannii carrying the rare blaOXA-237 was facilitated by transfer of affected patients without communication to receiving facilities. Infect Control Hosp Epidemiol 2017;38:1335-1341.

Entities:  

Mesh:

Year:  2017        PMID: 28870269      PMCID: PMC5783543          DOI: 10.1017/ice.2017.189

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  32 in total

1.  Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.

Authors:  Christopher D Pfeiffer; Margaret C Cunningham; Tasha Poissant; Jon P Furuno; John M Townes; Andrew Leitz; Ann Thomas; Genevieve L Buser; Robert F Arao; Zintars G Beldavs
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

2.  Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients.

Authors:  A O Ajao; G Robinson; M S Lee; T D Ranke; R A Venezia; J P Furuno; A D Harris; J K Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

3.  Global spread of carbapenem-resistant Acinetobacter baumannii.

Authors:  Paul G Higgins; Cathrin Dammhayn; Meredith Hackel; Harald Seifert
Journal:  J Antimicrob Chemother       Date:  2009-12-08       Impact factor: 5.790

4.  Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study.

Authors:  Kavitha Prabaker; Michael Y Lin; Margaret McNally; Kartikeya Cherabuddi; Sana Ahmed; Andrea Norris; Karen Lolans; Ruba Odeh; Vishnu Chundi; Robert A Weinstein; Mary K Hayden
Journal:  Infect Control Hosp Epidemiol       Date:  2012-10-25       Impact factor: 3.254

5.  OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Authors:  Paul G Higgins; Laurent Poirel; Marlene Lehmann; Patrice Nordmann; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

6.  Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility.

Authors:  Jon P Furuno; Joan N Hebden; Harold C Standiford; Eli N Perencevich; Ram R Miller; Anita C Moore; Sandra M Strauss; Anthony D Harris
Journal:  Am J Infect Control       Date:  2008-09       Impact factor: 2.918

7.  "Airborne assault": a new dimension in Acinetobacter baumannii transmission*.

Authors:  Brad Spellberg; Robert A Bonomo
Journal:  Crit Care Med       Date:  2013-08       Impact factor: 7.598

Review 8.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 9.  Challenges and Strategies for Prevention of Multidrug-Resistant Organism Transmission in Nursing Homes.

Authors:  Ghinwa Dumyati; Nimalie D Stone; David A Nace; Christopher J Crnich; Robin L P Jump
Journal:  Curr Infect Dis Rep       Date:  2017-04       Impact factor: 3.725

10.  Extensively drug-resistant Acinetobacter baumannii.

Authors:  Yohei Doi; Shahid Husain; Brian A Potoski; Kenneth R McCurry; David L Paterson
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more
  8 in total

1.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013-2017.

Authors:  Susannah L McKay; Nicholas Vlachos; Jonathan B Daniels; Valerie S Albrecht; Valerie A Stevens; J Kamile Rasheed; J Kristie Johnson; Joseph D Lutgring; Maria Sjölund-Karlsson; Alison Laufer Halpin
Journal:  Microb Drug Resist       Date:  2022-05-27       Impact factor: 2.706

2.  Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing blaOXA-237 Carried on a Plasmid.

Authors:  Andrea M Hujer; Paul G Higgins; Susan D Rudin; Genevieve L Buser; Steven H Marshall; Kyriaki Xanthopoulou; Harald Seifert; Laura J Rojas; T Nicholas Domitrovic; P Maureen Cassidy; Margaret C Cunningham; Robert Vega; Jon P Furuno; Christopher D Pfeiffer; Zintars G Beldavs; Meredith S Wright; Michael R Jacobs; Mark D Adams; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Investigation of a Carbapenemase-producing Acinetobacter baumannii outbreak using whole genome sequencing versus a standard epidemiologic investigation.

Authors:  Chloe Bogaty; Laura Mataseje; Andrew Gray; Brigitte Lefebvre; Simon Lévesque; Michael Mulvey; Yves Longtin
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-21       Impact factor: 4.887

4.  Rapid Replacement of Acinetobacter baumannii Strains Accompanied by Changes in Lipooligosaccharide Loci and Resistance Gene Repertoire.

Authors:  Mark D Adams; Meredith S Wright; James K Karichu; Pratap Venepally; Derrick E Fouts; Agnes P Chan; Sandra S Richter; Michael R Jacobs; Robert A Bonomo
Journal:  mBio       Date:  2019-03-26       Impact factor: 7.867

Review 5.  Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.

Authors:  Maria Soledad Ramirez; Robert A Bonomo; Marcelo E Tolmasky
Journal:  Biomolecules       Date:  2020-05-06

6.  Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit.

Authors:  Paula Eckardt; Kelsi Canavan; Rachel Guran; Elizabeth George; Nancimae Miller; Dianeysis H Avendano; Myeongji Kim; Khaled Himed; Karen Heidi Gonzalez Ramirez
Journal:  Am J Infect Control       Date:  2022-02-26       Impact factor: 4.303

7.  Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah.

Authors:  Amanda R Smith; Maureen Vowles; Roberta Z Horth; Lori Smith; Linda Rider; Jennifer M Wagner; Anna Sangster; Erin L Young; Hailey Schuckel; James Stewart; Randon J Gruninger; Alessandro Rossi; Kelly F Oakeson; Allyn K Nakashima
Journal:  Am J Infect Control       Date:  2020-11-17       Impact factor: 2.918

8.  Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice.

Authors:  Yunfen Hua; Tingting Luo; Yiqi Yang; Dong Dong; Rui Wang; Yanjun Wang; Mengsha Xu; Xiaokui Guo; Fupin Hu; Ping He
Journal:  Front Microbiol       Date:  2018-01-09       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.